| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 56,165 | 61,607 | 41,012 | 89,544 | | Cost of Revenue | 20,915 | 21,315 | 17,797 | 49,628 | | | Gross Profit | 35,250 | 40,292 | 23,215 | 39,916 | | | Operating Expenses | | Research Development | 14,141 | 15,501 | 16,353 | 15,780 | | Selling General and Administrative | 23,105 | 22,530 | 22,642 | 36,046 | | Non Recurring | 1,533 | (7) | 1,984 | 3,429 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,529) | 2,268 | (17,764) | (15,339) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 799 | 1,096 | 1,642 | 2,517 | | Earnings Before Interest And Taxes | (2,730) | 3,364 | (16,122) | (12,822) | | Interest Expense | 23 | (8) | 79 | 34 | | Income Before Tax | (2,753) | 3,372 | (16,201) | (12,856) | | Income Tax Expense | 644 | (1,011) | 26 | 86,126 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,397) | 4,383 | (16,227) | (98,982) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (924) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,397) | 4,383 | (16,227) | (99,906) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,397) | $4,383 | ($16,227) | ($99,906) |
|
0.12% Nasdaq 
0.01 (0.47%) 
Income Statement
